A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

NCT00449150 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal

NCT03887871 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers

NCT03887858 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia

NCT07146386 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

NCT00540124 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT00237536 ·Status: TERMINATED ·Phase: PHASE2

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

NCT00969072 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

NCT01922375 ·Status: COMPLETED ·Phase: PHASE4

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

NCT02417831 ·Status: COMPLETED ·Phase: PHASE1

Botulinum Toxin Injection for the Management of BPH

NCT00451191 ·Status: COMPLETED ·Phase: PHASE2

A Study in Men With Benign Prostatic Hyperplasia

NCT01097707 ·Status: TERMINATED ·Phase: PHASE2

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

NCT05236634 ·Status: UNKNOWN ·Phase: NA

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

NCT01301599 ·Status: COMPLETED ·Phase: PHASE4

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT00435448 ·Status: TERMINATED ·Phase: PHASE3

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

NCT00663858 ·Status: COMPLETED ·Phase: PHASE3

Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy

NCT02961114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

NCT00962390 ·Status: COMPLETED ·Phase: PHASE2

One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients

NCT00472251 ·Status: COMPLETED

Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

NCT07270432 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Single Center Comparative Trial of Trans-Perineal Laser Ablation Vs Water Vapor Ablation

NCT06794333 ·Status: COMPLETED ·Phase: NA

Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate

NCT01073241 ·Status: UNKNOWN ·Phase: NA

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

NCT00224107 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

NCT04947631 ·Status: COMPLETED ·Phase: PHASE3

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)

NCT01259531 ·Status: COMPLETED ·Phase: PHASE4

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605 ·Status: COMPLETED ·Phase: PHASE3